Physician
Carmili, David
Carmili, David was paid $482K by Medicaid between Jan 2018 and Dec 2024, across 43 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 49% of everything it billed.
33Billing provider infoCARMILI, DAVID
RIDGEWOOD, NY 11385
RIDGEWOOD, NY 11385
33aNPI1497856942assigned 09/26/2006
33bProvider typePediatrics Physician
28Total paid$482K
24GClaims26,008
24DCodes billed43
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#425 of 1,983
Median peer was paid$17K
This provider vs. median28×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,852 | $56K | |
| 2019 | 2,829 | $95K | |
| 2020 | 3,090 | $99K | |
| 2021 | 3,066 | $56K | |
| 2022 | 7,306 | $95K | |
| 2023 | 5,121 | $59K | |
| 2024incomplete | 2,744 | $21K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 49% | 8,102 | 6,726 | $236K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 25% | 4,869 | 2,507 | $119K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.7% | 526 | 465 | $23K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.9% | 4,107 | 2,162 | $19K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 229 | 228 | $17K |
| 31231 | 3.0% | 217 | 215 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 342 | 250 | $11K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 213 | 196 | $7K |
| 94060 | <1% | 107 | 107 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 418 | 389 | $4K |
| 99344 | <1% | 65 | 62 | $4K | |
| 93000 | <1% | 315 | 312 | $4K |
31 more codes
| 99349 | <1% | 98 | $3K | |
| 99442 | <1% | 131 | $3K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 645 | $3K |
| 92552 | <1% | 83 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 140 | $1K |
| 90688 | <1% | 167 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,978 | $1K |
| 3078F | <1% | 749 | $1K | |
| 3074F | <1% | 692 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 15 | $1K |
| 99441 | <1% | 184 | $841.31 | |
| 99072 | <1% | 13 | $162.50 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | $91.25 |
| 99173 | <1% | 58 | $88.29 | |
| 86580 | <1% | 12 | $81.11 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 151 | $78.51 |
| 85018 | <1% | 55 | $73.48 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 484 | $15.60 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $7.22 |
| 3351F | 0% | 426 | $0.00 | |
| 2010F | 0% | 44 | $0.00 | |
| 2001F | 0% | 44 | $0.00 | |
| 3008F | 0% | 42 | $0.00 | |
| 36000 | 0% | 19 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 19 | $0.00 |
| 2000F | 0% | 14 | $0.00 | |
| 1159F | 0% | 53 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 28 | $0.00 |
| 1160F | 0% | 56 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 60 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.